Forte Biosciences
FBRX
63 hedge funds and large institutions have $92M invested in Forte Biosciences in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 10 closing their positions.
110% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 10
79% more capital invested
Capital invested by funds: $51.5M → $92M (+$40.5M)
73% more call options, than puts
Call options by funds: $636K | Put options by funds: $367K
20% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 10
3% more funds holding
Funds holding: 61 → 63 (+2)
0.01% more ownership
Funds ownership: 0.07% → 0.08% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.89M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.41M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.35M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.04M |
| 5 |
PFA
Pure Financial Advisors
San Diego,
California
|
+$799K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$4.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.61M |
| 3 |
AG
Artal Group
Luxembourg
|
-$934K |
| 4 |
CI
CPMG Inc
Dallas,
Texas
|
-$815K |
| 5 |
LSAG
Lake Street Advisors Group
Portsmouth,
New Hampshire
|
-$458K |
FBRX Hedge Fund Activity: Q3 2018 in Review
63 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q3 2018, worth a combined $92M — up 79% from $51.5M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new FBRX positions and 10 closed out — a net gain of 2 holders — while 21 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, adding an estimated $2.89M. The largest seller was BVF Inc, exiting entirely with an estimated $4.4M sold.
- 63 institutional investors held Forte Biosciences (FBRX) as of Q3 2018, up from 61 in Q2 2018.
- Funds reported $92M of Forte Biosciences stock for Q3 2018, up 79% quarter-over-quarter.
- 12 funds opened new Forte Biosciences positions in Q3 2018 and 10 closed out, a net change of +2 holders.
- The largest Forte Biosciences buyer in Q3 2018 was BlackRock, an estimated $2.89M added.
- The largest Forte Biosciences seller in Q3 2018 was BVF Inc, an estimated $4.4M sold.
Based on aggregated 13F filings for Q3 2018.